Global Dermatomycoses Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Dermatomycoses Drug

• 1.1 Definition of Dermatomycoses Drug
• 1.2 Dermatomycoses Drug Segment by Type
  • 1.2.1 Global Dermatomycoses Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 BB-2603
  • 1.2.3 Clotrimazole
  • 1.2.4 Dapaconazole
  • 1.2.5 Others
• 1.3 Dermatomycoses Drug Segment by Applications
  • 1.3.1 Global Dermatomycoses Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Dermatomycoses Drug Overall Market
  • 1.4.1 Global Dermatomycoses Drug Revenue (2014-2025)
  • 1.4.2 Global Dermatomycoses Drug Production (2014-2025)
  • 1.4.3 North America Dermatomycoses Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Dermatomycoses Drug Status and Prospect (2014-2025)
  • 1.4.5 China Dermatomycoses Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Dermatomycoses Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Dermatomycoses Drug Status and Prospect (2014-2025)
  • 1.4.8 India Dermatomycoses Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Dermatomycoses Drug
• 2.3 Manufacturing Process Analysis of Dermatomycoses Drug
• 2.4 Industry Chain Structure of Dermatomycoses Drug

3 Development and Manufacturing Plants Analysis of Dermatomycoses Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Dermatomycoses Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Dermatomycoses Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Dermatomycoses Drug Production and Capacity Analysis
• 4.2 Dermatomycoses Drug Revenue Analysis
• 4.3 Dermatomycoses Drug Price Analysis
• 4.4 Market Concentration Degree

5 Dermatomycoses Drug Regional Market Analysis

• 5.1 Dermatomycoses Drug Production by Regions
  • 5.1.1 Global Dermatomycoses Drug Production by Regions
  • 5.1.2 Global Dermatomycoses Drug Revenue by Regions
• 5.2 Dermatomycoses Drug Consumption by Regions
• 5.3 North America Dermatomycoses Drug Market Analysis
  • 5.3.1 North America Dermatomycoses Drug Production
  • 5.3.2 North America Dermatomycoses Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Dermatomycoses Drug Import and Export
• 5.4 Europe Dermatomycoses Drug Market Analysis
  • 5.4.1 Europe Dermatomycoses Drug Production
  • 5.4.2 Europe Dermatomycoses Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Dermatomycoses Drug Import and Export
• 5.5 China Dermatomycoses Drug Market Analysis
  • 5.5.1 China Dermatomycoses Drug Production
  • 5.5.2 China Dermatomycoses Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Dermatomycoses Drug Import and Export
• 5.6 Japan Dermatomycoses Drug Market Analysis
  • 5.6.1 Japan Dermatomycoses Drug Production
  • 5.6.2 Japan Dermatomycoses Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Dermatomycoses Drug Import and Export
• 5.7 Southeast Asia Dermatomycoses Drug Market Analysis
  • 5.7.1 Southeast Asia Dermatomycoses Drug Production
  • 5.7.2 Southeast Asia Dermatomycoses Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Dermatomycoses Drug Import and Export
• 5.8 India Dermatomycoses Drug Market Analysis
  • 5.8.1 India Dermatomycoses Drug Production
  • 5.8.2 India Dermatomycoses Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Dermatomycoses Drug Import and Export

6 Dermatomycoses Drug Segment Market Analysis (by Type)

• 6.1 Global Dermatomycoses Drug Production by Type
• 6.2 Global Dermatomycoses Drug Revenue by Type
• 6.3 Dermatomycoses Drug Price by Type

7 Dermatomycoses Drug Segment Market Analysis (by Application)

• 7.1 Global Dermatomycoses Drug Consumption by Application
• 7.2 Global Dermatomycoses Drug Consumption Market Share by Application (2014-2019)

8 Dermatomycoses Drug Major Manufacturers Analysis

• 8.1 Anacor Pharmaceuticals Inc
  • 8.1.1 Anacor Pharmaceuticals Inc Dermatomycoses Drug Production Sites and Area Served
  • 8.1.2 Anacor Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Biolab Farmaceutica Ltda
  • 8.2.1 Biolab Farmaceutica Ltda Dermatomycoses Drug Production Sites and Area Served
  • 8.2.2 Biolab Farmaceutica Ltda Product Introduction, Application and Specification
  • 8.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Blueberry Therapeutics Ltd
  • 8.3.1 Blueberry Therapeutics Ltd Dermatomycoses Drug Production Sites and Area Served
  • 8.3.2 Blueberry Therapeutics Ltd Product Introduction, Application and Specification
  • 8.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Daewoong Pharmaceutical Co Ltd
  • 8.4.1 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Production Sites and Area Served
  • 8.4.2 Daewoong Pharmaceutical Co Ltd Product Introduction, Application and Specification
  • 8.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Dermala Inc
  • 8.5.1 Dermala Inc Dermatomycoses Drug Production Sites and Area Served
  • 8.5.2 Dermala Inc Product Introduction, Application and Specification
  • 8.5.3 Dermala Inc Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Helix BioMedix Inc
  • 8.6.1 Helix BioMedix Inc Dermatomycoses Drug Production Sites and Area Served
  • 8.6.2 Helix BioMedix Inc Product Introduction, Application and Specification
  • 8.6.3 Helix BioMedix Inc Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Novan Inc
  • 8.7.1 Novan Inc Dermatomycoses Drug Production Sites and Area Served
  • 8.7.2 Novan Inc Product Introduction, Application and Specification
  • 8.7.3 Novan Inc Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Sol-Gel Technologies Ltd
  • 8.8.1 Sol-Gel Technologies Ltd Dermatomycoses Drug Production Sites and Area Served
  • 8.8.2 Sol-Gel Technologies Ltd Product Introduction, Application and Specification
  • 8.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 TGV-Laboratories
  • 8.9.1 TGV-Laboratories Dermatomycoses Drug Production Sites and Area Served
  • 8.9.2 TGV-Laboratories Product Introduction, Application and Specification
  • 8.9.3 TGV-Laboratories Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Viamet Pharmaceuticals Inc
  • 8.10.1 Viamet Pharmaceuticals Inc Dermatomycoses Drug Production Sites and Area Served
  • 8.10.2 Viamet Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Vyome Biosciences Pvt Ltd

9 Development Trend of Analysis of Dermatomycoses Drug Market

• 9.1 Global Dermatomycoses Drug Market Trend Analysis
  • 9.1.1 Global Dermatomycoses Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Dermatomycoses Drug Regional Market Trend
  • 9.2.1 North America Dermatomycoses Drug Forecast 2019-2025
  • 9.2.2 Europe Dermatomycoses Drug Forecast 2019-2025
  • 9.2.3 China Dermatomycoses Drug Forecast 2019-2025
  • 9.2.4 Japan Dermatomycoses Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Dermatomycoses Drug Forecast 2019-2025
  • 9.2.6 India Dermatomycoses Drug Forecast 2019-2025
• 9.3 Dermatomycoses Drug Market Trend (Product Type)
• 9.4 Dermatomycoses Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Dermatomycoses Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List